AzTrials
AzTrials

Menstrual CycleNCT05088122

Hormonal Effect of Different Menstrual Phases on Dynamic Balance in Postpubertal Females

An observational study of Menstrual Cycle, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

High rate of injuries detected during certain periods of menstrual cycle, raised the suggestion of the effecacy of the female sex hormones on soft tissue and neuromuscular control with subsequent deterioration of postural stability and high injury prevalence in post pubertal females so the aim of the present study is… Read more about this study

Who is it for?
Ages 16 to 25 years, women onlyHealthy volunteers can take part
Conditions the study is for
Menstrual Cycle
How many people
36 participants
Where
No sites listed yet
Study dates
15 Oct 2021to 25 Jan 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 25 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Study population: Thirty-six, healthy postpubertal females , their ages will be ranged from 16-25 and BMI will be ranged from 18-27kg/m2, with regular menstrual cycle and with no any health condition that can affect the balance performance

Who may be able to join

  • All females will be virginal.
  • Their ages will range from 15-25 years.
  • Their body mass index (BMI) will range from 18-27 kg/m2.
  • All females will have regular menstrual cycle within average of 28 days.

Who cannot join

  • Females having menstrual irregularity.
  • Use of oral contraceptives or any hormonal treatment in the previous six months before participate in this study.
  • History of lower extremity injury, surgery or pain during ADL.
  • Females having any vestibular problems , otitis media, labyrinthitis or any inner ear problems that affect balance.

Trial locations and contacts

No sites are listed yet.

Manal A. el-shafei, lecturer contact

00201220664518

manalpt1989@gmail.com

Hager M.E. Abd-elaziz, Demonstrator contact

00201067647763 ext. 00201064262623

hager.mohy@deraya.edu.eg

About this study

Official title: Hormonal Effect Of Different Phases Of Menstrual Cycle On Postural Stability In Postpubertal Females: A Cross Sectional Repeated Measure Design

High rate of injuries detected during certain periods of menstrual cycle, raised the suggestion of the effecacy of the female sex hormones on soft tissue and neuromuscular control with subsequent deterioration of postural stability and high injury prevalence in post pubertal females so the aim of the present study is to investigate the effect of female sex hormones on postural stability in post pubertal females.

Read the detailed description

Thirty-six post pubertal females will participate in this study. They will be selected from students and graduates of Faculty of Physical Therapy, Deraya University and they will be assigned into one group. Postural stability assessment will be carried out throughout three menstrual cycle phases, early follicular, ovulation and mid luteal phases by Biodex balance system. The timing of menstrual cycle phases will be determined by measuring serum estradiol and progesterone level. The exact time of ovulation will be determined by urine lutenizing hormone ovulatory strip test.

Conditions
Menstrual Cycle
Being tested
no intervention
Keywords
Sex hormones, Postural stability, Menstrual cycle.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • no interventionOther

    no intervention, not applicable

Study groups in NCT05088122
Study groupRoleWhat they receive
one groupNot described
Receives: Other: no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. serum estradiol level

    used for accurate timing of menstrual cycle phases, follicular and midluteal.

    Measured: two months

  2. Anetro-posterior stability index

    Indicator for dynamic postural stability

    Measured: two months

  3. Medio-lateral stability index

    Indicator for dynamic postural stability

    Measured: two months

  4. Overall stability index

    Indicator for dynamic postural stability

    Measured: two months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2021
  2. Study start15 Oct 2021 (estimated)
  3. Primary completion25 Dec 2021 (estimated)
  4. Study completion25 Jan 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05088122
Sponsor's protocol ID
P.T.REC/012/003102
Status last verified
Oct 2021
First submitted
8 Oct 2021
Last updated
21 Oct 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Menstrual Cycle, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Manal A. el-shafei, lecturer (00201220664518, manalpt1989@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

serum estradiol level (time frame: two months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in